101 related articles for article (PubMed ID: 16954566)
1. 18F-FDG PET of thyroid nodules with inconclusive cytologic results.
Martínez-Duncker C; Hurtado-López LM
J Nucl Med; 2006 Sep; 47(9):1555; author reply 1555-6. PubMed ID: 16954566
[No Abstract] [Full Text] [Related]
2. 18F-FDG PET reduces unnecessary hemithyroidectomies for thyroid nodules with inconclusive cytologic results.
de Geus-Oei LF; Pieters GF; Bonenkamp JJ; Mudde AH; Bleeker-Rovers CP; Corstens FH; Oyen WJ
J Nucl Med; 2006 May; 47(5):770-5. PubMed ID: 16644746
[TBL] [Abstract][Full Text] [Related]
3. Preoperative FDG-PET imaging to assess the malignant potential of follicular neoplasms of the thyroid.
Smith RB; Robinson RA; Hoffman HT; Graham MM
Otolaryngol Head Neck Surg; 2008 Jan; 138(1):101-6. PubMed ID: 18165002
[TBL] [Abstract][Full Text] [Related]
4. Current role of radionuclide imaging in differentiated thyroid cancer.
Wong KT; Choi FP; Lee YY; Ahuja AT
Cancer Imaging; 2008 Sep; 8(1):159-62. PubMed ID: 18818134
[TBL] [Abstract][Full Text] [Related]
5. Role of 18F-fluorodeoxyglucose positron emission tomography in preoperative assessment of cytologically indeterminate thyroid nodules.
Sebastianes FM; Cerci JJ; Zanoni PH; Soares J; Chibana LK; Tomimori EK; de Camargo RY; Izaki M; Giorgi MC; Eluf-Neto J; Meneghetti JC; Pereira MA
J Clin Endocrinol Metab; 2007 Nov; 92(11):4485-8. PubMed ID: 17684046
[TBL] [Abstract][Full Text] [Related]
6. [Preoperative evaluation of cytologically indeterminate thyroid nodules with 18F-FDG PET].
Sebastianes FM; Cerci JJ; Soares Júnior J; Zanoni PH; Tomimori EK; Camargo RY; Meneghetti JC; Pereira MA
Arq Bras Endocrinol Metabol; 2008 Oct; 52(7):1176-83. PubMed ID: 19082307
[TBL] [Abstract][Full Text] [Related]
7. Combined [18F]Fluorodeoxyglucose positron emission tomography and computed tomography (FDG-PET/CT) for detection of recurrent, 131I-negative thyroid cancer.
Finkelstein SE; Grigsby PW; Siegel BA; Dehdashti F; Moley JF; Hall BL
Ann Surg Oncol; 2008 Jan; 15(1):286-92. PubMed ID: 17882493
[TBL] [Abstract][Full Text] [Related]
8. SUVmax of 18F-FDG PET/CT in the differential diagnosis of benign and malignant thyroid nodules according to tumor volume.
Kim TH; Ji YB; Song CM; Kim JY; Choi YY; Park JS; Tae K
World J Surg Oncol; 2015 Jul; 13():217. PubMed ID: 26179774
[TBL] [Abstract][Full Text] [Related]
9. Impact of 18F-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) in patients with biochemical evidence of recurrent or residual medullary thyroid cancer.
de Groot JW; Links TP; Jager PL; Kahraman T; Plukker JT
Ann Surg Oncol; 2004 Aug; 11(8):786-94. PubMed ID: 15289241
[TBL] [Abstract][Full Text] [Related]
10. Is it possible to predict malignancy in cases with focal thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography?
Fujii T; Yajima R; Yamaguchi S; Tsutsumi S; Asao T; Kuwano H
Am Surg; 2012 Jan; 78(1):141-3. PubMed ID: 22273333
[No Abstract] [Full Text] [Related]
11. 18F-fluorodeoxyglucose uptake in thyroid from positron emission tomogram (PET) for evaluation in cancer patients: high prevalence of malignancy in thyroid PET incidentaloma.
Kim TY; Kim WB; Ryu JS; Gong G; Hong SJ; Shong YK
Laryngoscope; 2005 Jun; 115(6):1074-8. PubMed ID: 15933524
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic impact of 18FDG-PET/CT in the management of iodine-negative recurrence of differentiated thyroid carcinoma.
Mirallié E; Guillan T; Bridji B; Resche I; Rousseau C; Ansquer C; Bodet-Milin C; Curtet C; Carnaille B; Murat A; Charbonnel B; Kraeber-Bodéré F
Surgery; 2007 Dec; 142(6):952-8; discussion 952-8. PubMed ID: 18063081
[TBL] [Abstract][Full Text] [Related]
13. Utility of fluorodeoxyglucose-PET in patients with differentiated thyroid carcinoma.
Zuijdwijk MD; Vogel WV; Corstens FH; Oyen WJ
Nucl Med Commun; 2008 Jul; 29(7):636-41. PubMed ID: 18528186
[TBL] [Abstract][Full Text] [Related]
14. [Diagnostic accuracy of 18F-FDG PET in residual or recurrent differentiated thyroid carcinoma with high thyroglobulin and negative 131-I whole-body scan].
Cabrera Martín MN; Pasamontes Pingarrón JA; Carreras Delgado JL; Lapeña Gutiérrez L; Delgado Bolton RC; Bittini Copano A; Pérez Castejón MJ; Fernández Pérez C
Rev Esp Med Nucl; 2007; 26(5):263-9. PubMed ID: 17910834
[TBL] [Abstract][Full Text] [Related]
15. The role of F-18-fluorodeoxyglucose positron emission tomography in the postoperative evaluation of differentiated thyroid cancer.
Alzahrani AS; Abouzied ME; Salam SA; Mohamed G; Rifai A; Al Sugair A; Amin T
Eur J Endocrinol; 2008 May; 158(5):683-9. PubMed ID: 18426827
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic accuracy and prognostic value of 18F-FDG PET in Hürthle cell thyroid cancer patients.
Pryma DA; Schöder H; Gönen M; Robbins RJ; Larson SM; Yeung HW
J Nucl Med; 2006 Aug; 47(8):1260-6. PubMed ID: 16883003
[TBL] [Abstract][Full Text] [Related]
17. Initial experience in use of fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography in thyroid carcinoma patients with elevated serum thyroglobulin but negative iodine-131 whole body scans.
Ong SC; Ng DC; Sundram FX
Singapore Med J; 2005 Jun; 46(6):297-301. PubMed ID: 15902358
[TBL] [Abstract][Full Text] [Related]
18. Dedifferentiated thyroid carcinoma: the imaging role of 18F-FDG PET and non-iodine radiopharmaceuticals.
AL-Nahhas A
Nucl Med Commun; 2004 Sep; 25(9):891-5. PubMed ID: 15319593
[No Abstract] [Full Text] [Related]
19. The feasibility of 11C-methionine-PET in diagnosis of solitary lung nodules/masses when compared with 18F-FDG-PET.
Hsieh HJ; Lin SH; Lin KH; Lee CY; Chang CP; Wang SJ
Ann Nucl Med; 2008 Jul; 22(6):533-8. PubMed ID: 18670862
[TBL] [Abstract][Full Text] [Related]
20. Determination of malignancy of thyroid nodules with positron emission tomography.
Bloom AD; Adler LP; Shuck JM
Surgery; 1993 Oct; 114(4):728-34; discussion 734-5. PubMed ID: 8211687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]